中晚期宫颈癌患者术前采用新辅助化疗治疗的疗效观察
详细信息 查看官网全文
- 论文作者：伍燕 ; 何孔明 ; 赵彩霞 ; 罗岳西 ; 罗祥力
- 年：2016
- 作者机构：川北医学院第二临床学院南充市中心医院妇产科;川北医学院第二临床学院南充市中心医院影像科;川北医学院第二临床学院南充市中心医院肿瘤科;
- 论文关键词：中晚期宫颈癌 ; 术前新辅助化疗 ; 治疗效果
- 英文论文关键词：locally advanced cerv ; ical cancer preoperative neoadjuvant chemotherapy treatment effect
- 会议召开时间：2016-11-25
- 会议录名称：湖南中医药大学学报2016/专集：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会论文集
- 语种：中文
- 分类号：R737.33
- 学会代码：HNZY
- 会议名称：国际数字医学会数字中医药分会成立大会暨首届数字中医药学术交流会
- 会议地点：中国广东珠海
- 主办单位：国际数字医学会、Digital Chinese Medicine
- 学会名称：湖南中医药大学期刊杂志社
- 页数：2
- 文件大小：2025k
- 原文格式：D
- 会议级别：全国
摘要
目的:研究将术前新辅助化疗应用于中晚期宫颈癌患者中的治疗效果。方法,对我院收治的中晚期宫颈癌患者进行随机选取,所有患者均收治于2013年1月-2015年12月,将80例患者使用数字随机表法进行分析,将单纯化疗治疗应用于40例对照组患者中,将新辅助化疗应用于40例观察组患者中,将两组患者治疗有效率以及副反应发生率等情况进行对比。结果:经研究证实,使用术前新辅助化疗的患者其治疗有效率明显比对照组高,上述差异经对比和检验P<0.05,存在统计学意义,同时观察组患者治疗副作用发生率比对照组低,但是组间差异经相关软件检验P>0.05,不存在统计学意义。结论:对于中晚期宫颈癌患者,使用术前新辅助化疗方法进行治疗能够提高疾病治疗效果,并且具有一定的安全可靠性,具有广泛使用价值。
objective: to study the preoperative neoadjuvant chemotherapy was applied to treatment of patients with locally advanced cervical cancer. Method of locally advanced cervical cancerpatients were randomly selected from our hospital, all patients were admitted in January 2013- December 2015, 80 patients with digital random table method were analyzed, and the pure chemotherapywas applied to 40 patients in control group, the new adjuvant chemotherapy was applied to 40 patients in the observation group of patients, the treatment effectiveness and side effects in both groups werecompared, and so on and so forth. Results: confirmed by research, the use of preoperative neoadjuvant chemotherapy in patients with the treatment effectiveness is significantly higher than the controlgroup, the differences between the comparison and test P < 0.05, there is statistical significance, at the same time observation group patients low incidence of side effects than the control group, but thegroup
objective: to study the preoperative neoadjuvant chemotherapy was applied to treatment of patients with locally advanced cervical cancer. Method of locally advanced cervical cancerpatients were randomly selected from our hospital, all patients were admitted in January 2013- December 2015, 80 patients with digital random table method were analyzed, and the pure chemotherapywas applied to 40 patients in control group, the new adjuvant chemotherapy was applied to 40 patients in the observation group of patients, the treatment effectiveness and side effects in both groups werecompared, and so on and so forth. Results: confirmed by research, the use of preoperative neoadjuvant chemotherapy in patients with the treatment effectiveness is significantly higher than the controlgroup, the differences between the comparison and test P < 0.05, there is statistical significance, at the same time observation group patients low incidence of side effects than the control group, but thegroup
引文
[1]刘青梅.中晚期宫颈癌患者术前采用新辅助化疗治疗的效果观察[J].大家健康(下旬版),2015(6):67-67,68.
[2]张铁英.中晚期宫颈癌患者术前采用新辅助化疗疗效观察[J].中国卫生标准管理,2015(19):62-63.
[3]雷蕾,蒋来,张雪芬等.新辅助化疗治疗中晚期宫颈癌21例[J].中国临床保健杂志,2012,15(4):404-405.
[4]汤凯雯,杜佩妍,吴蕴瑜等.同步放化疗与新辅助化疗在局部中晚期宫颈癌治疗中的临床疗效评价[J].中国医药指南,2012(27):98.
[5]李亚,张芳,冰清等.TP方案治疗局部晚期宫颈癌的临床疗效分析[J].当代医学,2015(28):149-149,150.
[6]王玎,李志英.术前新辅助化疗辅助治疗中晚期宫颈癌疗效观察[J].山东医药,2011,51(6):38-39.
[2]张铁英.中晚期宫颈癌患者术前采用新辅助化疗疗效观察[J].中国卫生标准管理,2015(19):62-63.
[3]雷蕾,蒋来,张雪芬等.新辅助化疗治疗中晚期宫颈癌21例[J].中国临床保健杂志,2012,15(4):404-405.
[4]汤凯雯,杜佩妍,吴蕴瑜等.同步放化疗与新辅助化疗在局部中晚期宫颈癌治疗中的临床疗效评价[J].中国医药指南,2012(27):98.
[5]李亚,张芳,冰清等.TP方案治疗局部晚期宫颈癌的临床疗效分析[J].当代医学,2015(28):149-149,150.
[6]王玎,李志英.术前新辅助化疗辅助治疗中晚期宫颈癌疗效观察[J].山东医药,2011,51(6):38-39.